| Active Ingredient | HYDROXYUREA |
| Therapeutic Class | ANTINEOPLASTICS |
| Indications | Chronic myeloid leukemia. |
| Caution |
Anorexia, nausea and vomiting, stomatitis, leukopenia, thrombocytopenia and anaemia-less marked than leukopenia, megaloblastosis, alopecia is rare. Directly inhibits DNA synthesis primari More ... |
| Dose Range | 20-30mg/kg/day administered as a single dose. |
| Drug Interactions | |
| Pregnancy | Hydroxyurea can cause fetal toxicity when administered to pregnant women, but po More ... |
| Breast Feeding | Hydroxyurea is distributed into milk. Breastfeeding is not recommended during hy More ... |